Crispina Calsada

Track

Insider profile

Currently holds a position at Regulus Therapeutics Inc

Performance

Overall performance
0.5
Performance over holding periods
0.5
30 days 90 days 120 days
Average return -30% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer Regulus Therapeutics Inc Aug. 30, 2019 -
Crispina Calsada's trades of Regulus Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-15 2025-01-14
PlS Planned sale
11,070 -12.7%
476.60
US$2,921,015 		11,070 -12.7% 476.60 US$2,921,015
2025-01-15 2025-01-13
PlS Planned sale
10,638 -37.9%
398.14
US$1,643,229 		10,638 -37.9% 398.14 US$1,643,229
2024-01-18 2024-01-18
S Sale
14,994 +23.0%
427.43
US$135,463 		14,994 +23.0% 427.43 US$135,463